CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-03 | Watanabe Todd Franklin President and CEO | Grant or award · Stock Option (Right to Buy) | +188,100 | 188,100 | ||
| 2022-03-03 | Burnett Patrick | Grant or award | +17,800 | 44,050 | ||
| 2022-03-03 | Burnett Patrick | Grant or award · Stock Option (Right to Buy) | +47,100 | 47,100 | ||
| 2022-03-03 | Matsuda Masaru SVP and General Counsel | Grant or award | +13,300 | 13,300 | ||
| 2022-03-03 | Matsuda Masaru SVP and General Counsel | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-03 | Lock Kenneth A. Chief Commercial Officer | Grant or award | +13,300 | 45,034 | ||
| 2022-03-03 | Lock Kenneth A. Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-03 | Burrows Scott L Chief Financial Officer | Grant or award | +13,300 | 35,559 | ||
| 2022-03-03 | Burrows Scott L Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-03 | Turney Patricia A. SVP, Operations | Grant or award | +13,300 | 32,136 | ||
| 2022-03-03 | Turney Patricia A. SVP, Operations | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-03 | OSBORNE DAVID W Chief Technical Officer | Grant or award | +13,300 | 260,282 | ||
| 2022-03-03 | OSBORNE DAVID W Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-03 | Moore Matthew Richard SVP and Chief Business Officer | Grant or award | +13,300 | 13,300 | ||
| 2022-03-03 | Moore Matthew Richard SVP and Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +35,300 | 35,300 | ||
| 2022-03-01 | Watanabe Todd Franklin President and CEO | Sale | −2,153 | $17.75 | $38K | 592,626 |
| 2022-03-01 | OSBORNE DAVID W Chief Technical Officer | Sale | −775 | $17.75 | $14K | 246,982 |
| 2022-03-01 | Burrows Scott L Chief Financial Officer | Sale | −420 | $17.75 | $7K | 22,259 |
| 2022-03-01 | Turney Patricia A. SVP, Operations | Sale | −936 | $17.75 | $17K | 18,836 |
| 2022-03-01 | Lock Kenneth A. Chief Commercial Officer | Sale | −935 | $17.75 | $17K | 31,734 |
Page 32 of 35 · 689 trades